Eli Lilly (LLY): 10% owner sold ~$2.4M
LILLY ENDOWMENT INC, 10% owner at Eli Lilly, sold ~$2.4M of Eli Lilly shares.
- ~$2.4M
- Approx. value · 2,700 sh @ $887.45
- 96.5M
- Holds after · shares reported
- Traded
- Feb 21, 2025
- Filed
- Feb 24, 2025
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Dec 9, 2024CongressDisclosed partial sale of LLY — reported range $1,001 - $15,000
- Dec 10, 2024CongressDisclosed partial sale of LLY — reported range $1,001 - $15,000
- Dec 11, 2024CongressDisclosed partial sale of LLY — reported range $1,001 - $15,000
- Dec 12, 2024CongressDisclosed partial sale of LLY — reported range $1,001 - $15,000
- Dec 13, 2024CongressDisclosed partial sale of LLY — reported range $1,001 - $15,000
- Dec 16, 2024CongressDisclosed partial sale of LLY — reported range $1,001 - $15,000
- Dec 18, 2024CongressDisclosed partial sale of LLY — reported range $1,001 - $15,000
- Dec 24, 2024CongressDisclosed purchase of LLY — reported range $1,001 - $15,000
- Jan 8, 2025CongressDisclosed partial sale of LLY — reported range $1,001 - $15,000
- Jan 15, 2025FDAFDA drug approval: Omvoh
- Jan 15, 2025FDAFDA drug approval: Omvoh
- Jan 21, 2025CongressDisclosed purchase of LLY — reported range $1,001 - $15,000
- Jan 22, 2025CongressDisclosed purchase of LLY — reported range $50,001 - $100,000
- Jan 27, 2025FDAFDA drug approval: Cyramza
- Feb 6, 2025Insider · 1 personInsiders: 22 sales (~$183.6M)
- Feb 10, 2025Insider · 1 personInsiders: 3 sales (~$4.3M)
- Feb 10, 2025CongressDisclosed sale of LLY — reported range $50,001 - $100,000
- Feb 13, 2025Insider · 1 personInsiders: 7 sales (~$31.2M)
- Feb 19, 2025Insider · 1 personInsiders: 4 sales (~$8.8M)
- Feb 20, 2025Insider · 1 personInsiders: 4 sales (~$12.9M)
- Feb 21, 2025 · this disclosureInsider10% owner sold ~$2.4M of LLY shares in the open market
What came next
- Feb 21, 2025Insider · 1 personInsiders: 16 sales (~$85.4M)
- Feb 24, 2025Insider · 1 personInsiders: 11 sales (~$43.6M)
- Apr 7, 2025FDAFDA drug approval: Cyramza
How to read SEC Form 4
Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.
Full guide: What is an SEC Form 4?
What else is on file for Eli Lilly
For Eli Lilly, OQRO holds 4 insider filings (SEC Form 4 or Form 144), 3 Congress trade reports, 5 fund holdings reports (13F) and 1 federal contract award dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its LLY page.
Other recent filings by LILLY ENDOWMENT INC, 10% owner
- SEC Form 4 at Eli Lilly (LLY)May 7, 2026
- SEC Form 4 at Eli Lilly (LLY)May 7, 2026
- SEC Form 4 at Eli Lilly (LLY)Jan 8, 2026
- SEC Form 4 at Eli Lilly (LLY)Jan 8, 2026
- SEC Form 4 at Eli Lilly (LLY)Jan 8, 2026
The full history of LILLY ENDOWMENT INC, 10% owner is on the profile page.
How this filing works
Explore the data
Common questions
Which Eli Lilly (LLY) insider traded, and how much?
LILLY ENDOWMENT INC, 10% owner at Eli Lilly, sold ~$2.4M of Eli Lilly shares. 2,700 shares at $887.45.
When did it happen, and when was it made public?
Traded: Feb 21, 2025. Filed: Feb 24, 2025. That is 3 days between the two dates.
Is the dollar amount exact?
It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.
Where does this information come from?
From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.
What else has been disclosed about Eli Lilly recently?
For Eli Lilly, OQRO holds 4 insider filings (SEC Form 4 or Form 144), 3 Congress trade reports, 5 fund holdings reports (13F) and 1 federal contract award dated in the last 90 days. They are listed on the LLY page.
Does this mean LLY stock is a buy or a sell?
No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.
Is OQRO free?
Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.
Other disclosures at Eli Lilly
- SEC Form 13F-HRNov 16, 2026
- SEC Form 13F-HRNov 16, 2026
- SEC Form 13F-HRNov 13, 2026
- House Clerk periodic transaction reportNov 12, 2026
- House Clerk periodic transaction reportNov 12, 2026
- House Clerk periodic transaction reportNov 10, 2026
Everything OQRO holds on this company is on its LLY page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO is free for everyone. No card, no trial
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
